- Home
- / Northwest Biotherapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Northwest Biotherapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.3
2024-10-29
Market Capitalization
$349.5 M
2024-10-29
Revenue
$1.4 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.0K | 772.0K | 809.0K | 1.5M | 1.7M | 623.0K | 336.0K | 412.0K | 2.4M | 1.3M | 1.0M | 1.7M | 1.9M | 1.4M | 1.4M |
| Gross profit | 10.0K | 772.0K | 809.0K | ||||||||||||
| Gross profit margin, % | 100.0% | 100.0% | 100.0% | ||||||||||||
| General and administrative expense | 13.3M | 15.7M | 12.4M | 16.9M | 24.9M | 10.9M | 12.5M | 22.5M | 12.5M | 51.0M | 33.4M | 33.4M | 29.7M | 33.0M | 32.5M |
| Operating expense total | 26.8M | 44.6M | 58.3M | 102.6M | 128.0M | 70.9M | 46.0M | 40.7M | 26.1M | 84.6M | 68.9M | 67.9M | 61.3M | ||
| Depreciation and amortization | 10.0K | 14.0K | 12.0K | 11.0K | |||||||||||
| EBIT | (26.8M) | (43.8M) | (57.5M) | (101.1M) | (126.3M) | (79.3M) | (54.7M) | (41.5M) | (27.5M) | (86.6M) | (52.7M) | (67.2M) | (55.5M) | (66.5M) | (59.9M) |
| EBIT margin, % | -267870.0% | -5676.8% | -7104.2% | -6956.2% | -7261.9% | -12723.3% | -16273.2% | -10068.2% | -1139.5% | -6708.4% | -3991.7% | -4812.4% | -4347.9% | ||
| Interest income | 449.0K | ||||||||||||||
| Interest expense | 7.6M | 13.4M | 5.2M | ||||||||||||
| Pre tax profit | (60.7M) | ||||||||||||||
| Income tax expense | (537.0K) | ||||||||||||||
| Net Income | (32.8M) | (67.3M) | (65.8M) | (135.6M) | (114.7M) | (80.2M) | (73.1M) | (35.8M) | (20.3M) | (529.8M) | 179.1M | (105.0M) | (62.8M) | (83.8M) | (60.2M) |
| EPS | (0.1) | (0.1) | 0.0 |